Iron-dependent ferroptosis in cardiac microvascular endothelial cells: a key link between dysregulated iron homeostasis and microcirculatory injury during myocardial ischemia-reperfusion - Scorecard - MDSpire
Advertisement
Iron-dependent ferroptosis in cardiac microvascular endothelial cells: a key link between dysregulated iron homeostasis and microcirculatory injury during myocardial ischemia-reperfusion
Clinical Scorecard: Ferroptosis Driven by Iron in Cardiac Microvascular Endothelial Cells: A Critical Connection Between Altered Iron Regulation and Microcirculatory Damage in Myocardial Ischemia-Reperfusion
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients undergoing reperfusion therapy for acute myocardial infarction or cardiac surgery, specifically those at risk for myocardial ischemia-reperfusion injury.
Care Setting
Key Highlights
Add a highlight: 'Reactive oxygen species (ROS) contribute to exacerbating injury during reperfusion.'
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Monitor for signs of microvascular obstruction and assess endothelial function post-reperfusion, including specific parameters like capillary refill time and perfusion index.
Risks
Patient & Prescribing Data
Patients with acute myocardial infarction or undergoing cardiac surgery.
Emerging therapies targeting CMEC ferroptosis may improve microvascular reperfusion outcomes.
Clinical Best Practices
Add: 'Implement early intervention strategies to prevent ferroptosis in CMECs.'
Joint clinical consensus outlines evaluation and management considerations for arrhythmias, coronary atherosclerosis, aortic dilatation, myocardial fibrosis, and related findings in older competitive athletes.
